Subscribe to RSS
DOI: 10.1055/a-2706-1268
Does Debridement of Intracranial Disease in Acute Invasive Fungal Sinusitis Improve Survival?
Authors
Funding Information Internal departmental funding was utilized without commercial sponsorship or support.

Abstract
Background
Intracranial (IC) extension is a poor prognostic factor for acute invasive fungal sinusitis (IFS). There are no studies on the role of IC debridement in the setting of rhinocerebral IFS.
Methods
We retrospectively reviewed patients with rhinocerebral IFS confirmed on imaging who underwent surgical management. Patients who underwent sinonasal debridement only (reference group) were compared with those who underwent sinonasal and IC debridement (IC group). The primary outcome was overall survival. Univariate analysis and logistic regression were performed to assess for differences in clinical characteristics between the treatment groups and predictive factors of survival.
Results
Twenty-nine patients were included in the study, with 10 patients in the IC group and 19 patients in the reference group. There were no significant differences in patient demographics or predisposing conditions between the groups. Regarding IC extent of fungal disease, there were no significant differences in rates of dural, leptomeningeal, or parenchymal involvement; cavernous sinus extension; or cisternal cranial nerve involvement. The IC group had significantly more IC abscesses (60%) than the reference group (5%, p = 0.002). At the time of the most recent follow-up (month, year), 30% (n = 3) of the IC group, and 79% (n = 15) of the reference group had died (p = 0.02). The Cox proportional hazards model demonstrated a 93% reduction in the risk of death with IC debridement when adjusting for all covariables (p = 0.004).
Conclusion
This study is the largest series to examine neurosurgical management of rhinocerebral IFS, demonstrating possible survival benefit with IC debridement in select patients and with highly specialized surgical expertise.
Note
This work was previously presented in ISIAN and IRS 2024, Tokyo, Japan; April 4 to 6, 2024.
Publication History
Received: 07 April 2025
Accepted: 18 September 2025
Article published online:
09 October 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Turner JH, Soudry E, Nayak JV, Hwang PH. Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence. Laryngoscope 2013; 123 (05) 1112-1118
- 2 Thompson III GR, Patterson TF. Fungal disease of the nose and paranasal sinuses. J Allergy Clin Immunol 2012; 129 (02) 321-326
- 3 Chen CY, Sheng WH, Cheng A. et al. Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan. BMC Infect Dis 2011; 11: 250
- 4 Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47 (04) 503-509
- 5 Nam SH, Chung YS, Choi YJ, Lee JH, Kim JH. Treatment outcomes in acute invasive fungal rhinosinusitis extending to the extrasinonasal area. Sci Rep 2020; 10 (01) 3688
- 6 Roxbury CR, Smith DF, Higgins TS. et al. Complete surgical resection and short-term survival in acute invasive fungal rhinosinusitis. Am J Rhinol Allergy 2017; 31 (02) 109-116
- 7 Vaughan C, Bartolo A, Vallabh N, Leong SC. A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis-has anything changed in the past 20 years?. Clin Otolaryngol 2018; 43 (06) 1454-1464
- 8 D'Andrea MR, Gill CM, Umphlett M. et al. Benefit of endoscopic surgery in the management of acute invasive skull base fungal rhinosinusitis. J Neurol Surg B Skull Base 2021; 82 (Suppl. 03) e330-e334
- 9 Payne SJ, Mitzner R, Kunchala S, Roland L, McGinn JD. Acute invasive fungal rhinosinusitis: a 15-year experience with 41 patients. Otolaryngol Head Neck Surg 2016; 154 (04) 759-764
- 10 Kasapoglu F, Coskun H, Ozmen OA, Akalin H, Ener B. Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures. Otolaryngol Head Neck Surg 2010; 143 (05) 614-620
- 11 Bakhshaee M, Bojdi A, Allahyari A. et al. Acute invasive fungal rhinosinusitis: our experience with 18 cases. Eur Arch Otorhinolaryngol 2016; 273 (12) 4281-4287
- 12 Monroe MM, McLean M, Sautter N. et al. Invasive fungal rhinosinusitis: a 15-year experience with 29 patients. Laryngoscope 2013; 123 (07) 1583-1587
- 13 Abu El-Naaj I, Leiser Y, Wolff A, Peled M. The surgical management of rhinocerebral mucormycosis. J Craniomaxillofac Surg 2013; 41 (04) 291-295
- 14 Ma J, Jia R, Li J. et al. Retrospective clinical study of eighty-one cases of intracranial mucormycosis. J Glob Infect Dis 2015; 7 (04) 143-150
- 15 Saito K, Fukuta K, Takahashi M, Tachibana E, Yoshida J. Management of the cavernous sinus in en bloc resections of malignant skull base tumors. Head Neck 1999; 21 (08) 734-742
- 16 Couldwell WT, MacDonald JD, Taussky P. Complete resection of the cavernous sinus-indications and technique. World Neurosurg 2014; 82 (06) 1264-1270
- 17 Hoenigl M, Arastehfar A, Arendrup MC. et al. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clin Microbiol Rev 2024; 37 (02) e0007423
- 18 Jenks JD, White PL, Kidd SE. et al. An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections. Expert Rev Mol Diagn 2023; 23 (12) 1135-1152
